MicroRNAs as therapeutic targets and their potential applications in cancer therapy

Bibliography

• Cho WC. Conquering cancer through discovery research. IUBMB Life 2010;62:655-9
   PubMed Web of Science ®Google Scholar
• Almeida MI, Reis RM, Calin GA. microRNA history: discovery, recent applications, and next frontiers. Mutat Res 2011;717:1-8
   PubMed Web of Science ®Google Scholar
• Cho WC. microRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol 2010;42:1273-81
   PubMed Web of Science ®Google Scholar
• Cho WC. microRNAs in cancer - from research to therapy. Biochim Biophys Acta 2010;1805:209-17
   PubMed Web of Science ®Google Scholar
• Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis 2010;31:27-36
   PubMed Web of Science ®Google Scholar
• Chen T. The role of MicroRNA in chemical carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2010;28:89-124
   Web of Science ®Google Scholar
• Koturbash I, Zemp FJ, Pogribny I, Small molecules with big effects: the role of the microRNAome in cancer and carcinogenesis. Mutat Res 2011;722:94-105
   Web of Science ®Google Scholar
• Bueno MJ, Malumbres M. microRNAs and the cell cycle. Biochim Biophys Acta 2011;1812:592-601
   PubMed Web of Science ®Google Scholar
• Babashah S, Soleimani M. The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis. Eur J Cancer 2011;47:1127-37
   PubMed Web of Science ®Google Scholar
• Leucci E, Zriwil A, Gregersen LH, Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo. Oncogene 2012; publish 6 Feb 2012; doi:10.1038/onc.2012.15
   Google Scholar
• Zheng YS, Zhang H, Zhang XJ, miR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia. Oncogene 2012;31:80-92
   PubMed Web of Science ®Google Scholar
• Lee DW, Futami M, Carroll M, Loss of SHIP-1 protein expression in high-risk myelodysplastic syndromes is associated with miR-210 and miR-155. Oncogene 2012; publish online 16 Jan 2012; doi:10.1038/onc.2011.579
   Google Scholar
• Cai C, Ashktorab H, Pang X, microRNA-211 expression promotes colorectal cancer cell growth in vitro and in vivo by targeting tumor suppressor CHD5. PLoS ONE 2012;7:e29750
   PubMed Web of Science ®Google Scholar
• Lu Z, Li Y, Takwi A, miR-301a as an NF-kappaB activator in pancreatic cancer cells. EMBO J 2011;30:57-67
   PubMed Web of Science ®Google Scholar
• Jin Z, Selaru FM, Cheng Y, microRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro. Oncogene 2011;30:1577-85
   PubMed Web of Science ®Google Scholar
• Li X, Zhang Y, Zhang H, miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res 2011;9:824-33
   PubMed Web of Science ®Google Scholar
• Yang MH, Lin BR, Chang CH, Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling. Oncogene 2012;31:2401-11
   Google Scholar
• Jalava SE, Urbanucci A, Latonen L, Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer. Oncogene 2012; publish online 23 Jan 2012; doi:10.1038/onc.2011.624
   Google Scholar
• Kim K, Chadalapaka G, Lee SO, Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer. Oncogene 2012;31:1034-44
   PubMed Web of Science ®Google Scholar
• Turcatel G, Rubin N, El-Hashash A, miR-99a and miR-99b modulate TGF-beta induced epithelial to mesenchymal plasticity in normal murine mammary gland cells. PLoS One 2012;7:e31032
   PubMed Web of Science ®Google Scholar
• Smith AL, Iwanaga R, Drasin DJ, The miR-106b-25 cluster targets Smad7, activates TGF-beta signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene 2012; publish online 30 Jan 2012; doi:10.1038/onc.2012.11
   Google Scholar
• Wang Y, Yu Y, Tsuyada A, Transforming growth factor-beta regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM. Oncogene 2011;30:1470-80
   PubMedGoogle Scholar
• Yan LX, Wu QN, Zhang Y, Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth. Breast Cancer Res 2011;13:R2
   PubMed Web of Science ®Google Scholar
• van der Fits L, van Kester MS, Qin Y, microRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sezary syndrome. J Invest Dermatol 2011;131:762-8
   PubMed Web of Science ®Google Scholar
• Kwak HJ, Kim YJ, Chun KR, Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene 2011;30:2433-42
   Google Scholar
• Gabriely G, Yi M, Narayan RS, Human glioma growth is controlled by microRNA-10b. Cancer Res 2011;71:3563-72
   PubMed Web of Science ®Google Scholar
• Kim K, Lee HC, Park JL, Epigenetic regulation of microRNA-10b and targeting of oncogenic MAPRE1 in gastric cancer. Epigenetics 2011;6:740-51
   PubMed Web of Science ®Google Scholar
• Nishida N, Mimori K, Fabbri M, microRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab. Clin Cancer Res 2011;17:2725-33
   PubMed Web of Science ®Google Scholar
• Zheng B, Liang L, Huang S, microRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers. Oncogene 2012; publish online 9 Dec 2011; doi:10.1038/onc.2011.581
   Google Scholar
• Fang YX, Xue JL, Shen Q, miR-7 inhibits tumor growth and metastasis by targeting the PI3K/AKT pathway in hepatocellular carcinoma. Hepatology 2012;55:1852-62
   PubMed Web of Science ®Google Scholar
• Lee KM, Choi EJ, Kim IA. microRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling. Radiother Oncol 2011;101:171-6
   PubMed Web of Science ®Google Scholar
• Saydam O, Senol O, Wurdinger T, miRNA-7 attenuation in Schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways. Cancer Res 2011;71:852-61
   PubMed Web of Science ®Google Scholar
• Cho WC, Chow AS, Au JS. miR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1. RNA Biol 2011;8:125-31
   PubMed Web of Science ®Google Scholar
• Zhang J, Sun Q, Zhang Z, Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop. Oncogene 2012; publish online 13 Feb 2012; doi:10.1038/onc.2012.28
   Google Scholar
• Zhang JG, Guo JF, Liu DL, microRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2. J Thorac Oncol 2011;6:671-8
   PubMed Web of Science ®Google Scholar
• Feng S, Cong S, Zhang X, microRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells. Nucleic Acids Res 2011;39:6669-78
   PubMed Web of Science ®Google Scholar
• Paik JH, Jang JY, Jeon YK, microRNA-146a downregulates NFkappaB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma. Clin Cancer Res 2011;17:4761-71
   PubMed Web of Science ®Google Scholar
• Thomas M, Lange-Grunweller K, Weirauch U, The proto-oncogene Pim-1 is a target of miR-33a. Oncogene 2012;31:918-28
   PubMed Web of Science ®Google Scholar
• Baraniskin A, Birkenkamp-Demtroder K, Maghnouj A, miR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL. Carcinogenesis 2012;33:732-9
   PubMed Web of Science ®Google Scholar
• Song Y, Xu Y, Wang Z, microRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer. Int J Cancer 2012; publish online 23 Oct 2011; doi:10.1002/ijc.26485
   Google Scholar
• Wu J, Wu G, Lv L, microRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. Carcinogenesis 2012;33:519-28
   PubMed Web of Science ®Google Scholar
• Liu C, Kelnar K, Liu B, The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 2011;17:211-15
   PubMed Web of Science ®Google Scholar
• Lee YM, Lee JY, Ho CC, microRNA 34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells. Breast Cancer Res 2011;13:R116
   Google Scholar
• Wu G, Yu F, Xiao Z, Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro. Br J Cancer 2011;105:146-53
   PubMedGoogle Scholar
• Zhang W, Kong G, Zhang J, microRNA-520b inhibits growth of hepatoma cells by targeting MEKK2 and Cyclin D1. PLoS One 2012;7:e31450
   Google Scholar
• Almeida MI, Nicoloso MS, Zeng L, Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells. Gastroenterology 2012;142:886-96. e9
   PubMed Web of Science ®Google Scholar
• Kim SJ, Shin JY, Lee KD, microRNA let-7a suppresses breast cancer cell migration and invasion through down-regulation of C-C chemokine receptor type 7. Breast Cancer Res 2012;14:R14
   PubMed Web of Science ®Google Scholar
• Wu ZS, Wu Q, Wang CQ, miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met. Cancer 2011;117:2842-52
   PubMed Web of Science ®Google Scholar
• Srivastava SK, Bhardwaj A, Singh S, microRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells. Carcinogenesis 2011;32:1832-9
   PubMed Web of Science ®Google Scholar
• Viticchie G, Lena AM, Latina A, miR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines. Cell Cycle 2011;10:1121-31
   PubMed Web of Science ®Google Scholar
• Saini S, Majid S, Yamamura S, Regulatory role of miR-203 in prostate cancer progression and metastasis. Clin Cancer Res 2011;17:5287-98
   PubMed Web of Science ®Google Scholar
• Wei JJ, Wu X, Peng Y, Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasion. Clin Cancer Res 2011;17:1297-305
   PubMed Web of Science ®Google Scholar
• Qi J, Rice SJ, Salzberg AC, miR-365 regulates lung cancer and developmental gene thyroid transcription factor 1. Cell Cycle 2012;11:177-86
   PubMed Web of Science ®Google Scholar
• Yamagishi M, Nakano K, Miyake A, Polycomb-mediated loss of miR-31 activates NIK-dependent NF-kappaB pathway in adult T cell leukemia and other cancers. Cancer Cell 2012;21:121-35
   PubMed Web of Science ®Google Scholar
• De Weer A, Van der Meulen J, Rondou P, EVI1-mediated down regulation of miR449a is essential for the survival of EVI1 positive leukaemic cells. Br J Haematol 2011;154:337-48
   Google Scholar
• Tian X, Liu Z, Niu B, E-cadherin/beta-catenin complex and the epithelial barrier. J Biomed Biotechnol 2011;2011:567305
   PubMedGoogle Scholar
• Hirata H, Hinoda Y, Ueno K, microRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer. Carcinogenesis 2012;33:41-8
   Google Scholar
• Hirata H, Hinoda Y, Ueno K, microRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer. Carcinogenesis 2012;33:501-8
   PubMed Web of Science ®Google Scholar
• Chung TK, Lau TS, Cheung TH, Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1. Int J Cancer 2012;130:1036-45
   PubMed Web of Science ®Google Scholar
• Zhang L, Sullivan PS, Goodman JC, microRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase. Cancer Res 2011;71:645-54
   PubMed Web of Science ®Google Scholar
• Kasinski AL, Slack FJ. Epigenetics and genetics. microRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011;11:849-64
   PubMed Web of Science ®Google Scholar
• Cho WC. Exploiting the therapeutic potential of microRNAs in human cancer. Expert Opin Ther Targets 2012;16:345-50
   PubMed Web of Science ®Google Scholar
• Gong C, Yao Y, Wang Y, Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer. J Biol Chem 2011;286:19127-37
   PubMed Web of Science ®Google Scholar
• Kastl L, Brown I, Schofield AC. miRNA-34a is associated with docetaxel resistance in human breast cancer cells. Breast Cancer Res Treat 2012;131:445-54
   PubMed Web of Science ®Google Scholar
• Nalls D, Tang SN, Rodova M, Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells. PLoS One 2011;6:e24099
   PubMed Web of Science ®Google Scholar
• de Antonellis P, Medaglia C, Cusanelli E, MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma. PLoS One 2011;6:e24584
   PubMed Web of Science ®Google Scholar
• Hikichi M, Kidokoro M, Haraguchi T, microRNA regulation of glycoprotein B5R in oncolytic vaccinia virus reduces viral pathogenicity without impairing its antitumor efficacy. Mol Ther 2011;19:1107-15
   PubMed Web of Science ®Google Scholar
• Ibrahim AF, Weirauch U, Thomas M, microRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Cancer Res 2011;71:5214-24
   PubMed Web of Science ®Google Scholar
• Kim SJ, Oh JS, Shin JY, Development of microRNA-145 for therapeutic application in breast cancer. J Control Release 2011;155:427-34
   PubMed Web of Science ®Google Scholar
• Yang YP, Chien Y, Chiou GY, Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI. Biomaterials 2012;33:1462-76
   PubMed Web of Science ®Google Scholar
• Zhang S, Shan C, Kong G, microRNA-520e suppresses growth of hepatoma cells by targeting the NF-kappaB-inducing kinase (NIK). Oncogene 2012; publish online 21 Nov 2011; doi:10.1038/onc.2011.523
   Google Scholar
• He XX, Chang Y, Meng FY, microRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene 2012; publish online 7 Nov 2011; doi:10.1038/onc.2011.500
   Google Scholar
• Taby R, Issa JP. Cancer epigenetics. CA Cancer J Clin 2010;60:376-92
   PubMed Web of Science ®Google Scholar
• Cho WC. Epigenomics. In: Schwab M, editor. Encyclopedia of cancer. 3rd edition. Springer; Heidelberg: 2012. In press
   Google Scholar
• Cho WC. Targeting the signaling pathways in cancer therapy. Expert Opin Ther Targets 2012;16:1-3
   PubMed Web of Science ®Google Scholar
• Garofalo M, Croce CM. microRNAs: master regulators as potential therapeutics in cancer. Annu Rev Pharmacol Toxicol 2011;51:25-43
   PubMed Web of Science ®Google Scholar
• Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 2010;9:775-89
   PubMed Web of Science ®Google Scholar
• Cho WC. Grand challenges and opportunities in deciphering the role of non-coding RNAs in human diseases. Front Genet 2011;2:1
   PubMedGoogle Scholar
• Cortez MA, Ivan C, Zhou P, microRNAs in cancer: from bench to bedside. Adv Cancer Res 2010;108:113-57
   PubMed Web of Science ®Google Scholar